WATSON 461 (Glipizide 10 mg)
Pill imprint WATSON 461 has been identified as Glipizide 10 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.
See also related documents.
- 10 mg
- 10.00 mm
- Prescription only
|NDC Code||Manufacturer / Repackager|
|63739-0117||McKesson Packaging Services|
|54569-3842||A-S Medication Solutions, LLC (repackager)|
|67544-0129||Prepak Systems Inc (repackager)|
|16590-0287||Stat RX USA LLC (repackager)|
|68258-1013||Dispensing Solutions Inc. (repackager)|
|66336-0662||Dispensing Solutions Inc. (repackager)|
|58016-0376||Southwood Pharmaceuticals Inc (repackager)|
|63874-0432||Altura Pharmaceuticals Inc (repackager)|
|54868-3319||Physicians Total Care Inc (repackager)|
|21695-0470||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about glipizide
Related treatment guides
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.